These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11037061)

  • 21. CD102 (ICAM-2).
    Ybarrondo B; Shih CC
    J Biol Regul Homeost Agents; 2001; 15(2):188-9. PubMed ID: 11501981
    [No Abstract]   [Full Text] [Related]  

  • 22. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
    Hassan NJ; Barclay AN; Brown MH
    Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD2.
    Schraven B
    J Biol Regul Homeost Agents; 2000; 14(3):223-5. PubMed ID: 11037058
    [No Abstract]   [Full Text] [Related]  

  • 24. CD3 complex.
    Ernst DN; Shih CC
    J Biol Regul Homeost Agents; 2000; 14(3):226-9. PubMed ID: 11037059
    [No Abstract]   [Full Text] [Related]  

  • 25. Inducible costimulator-ligand (ICOS-L).
    Flesch IE
    J Biol Regul Homeost Agents; 2002; 16(3):217-9. PubMed ID: 12456022
    [No Abstract]   [Full Text] [Related]  

  • 26. CD6 molecule may be important in the pathological mechanisms of lymphocytes adhesion to human skin in psoriasis and ior t1 MAb a possible new approach to treat this disease.
    Montero E; Falcon L; Morera Y; Delgado J; Amador JF; Perez R
    Autoimmunity; 1999; 29(2):155-6. PubMed ID: 10433078
    [No Abstract]   [Full Text] [Related]  

  • 27. Cloning and functional expression of the T cell activation antigen CD26.
    Tanaka T
    J Immunol; 1993 Mar; 150(5):2090. PubMed ID: 8094732
    [No Abstract]   [Full Text] [Related]  

  • 28. A symmetrical view of the T-cell receptor-CD3 complex.
    Rojo JM; Portoleś P
    Immunol Today; 1991 Oct; 12(10):377-8. PubMed ID: 1835580
    [No Abstract]   [Full Text] [Related]  

  • 29. CD5. Other names: T1, Leu-1, Tp67 (human), and Ly-1 (mouse).
    Alaverdi N; Shih CC
    J Biol Regul Homeost Agents; 2000; 14(3):230-3. PubMed ID: 11037060
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
    Yousef GM; Ordon MH; Foussias G; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heads Or Tails: Betting On CD6 As a Resurged Target For Autoimmune Diseases and Sepsis.
    Carmo AM
    Curr Drug Targets; 2016; 17(6):618. PubMed ID: 27017998
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of allelic variants of the bovine immune regulatory molecule CEACAM1 implies a pathogen-driven evolution.
    Kammerer R; Popp T; Singer BB; Schlender J; Zimmermann W
    Gene; 2004 Sep; 339():99-109. PubMed ID: 15363850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD6 and the UCHL1-defined CD45 (p180) antigen by human colonic T lymphocytes.
    Smart CJ; Heatley RV; Trejdosiewicz LK
    Immunology; 1989 Jan; 66(1):90-5. PubMed ID: 15493268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
    Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface.
    Vance BA; Harley PH; Backlund PS; Ward Y; Phelps TL; Gress RE
    Arch Biochem Biophys; 2005 Jun; 438(1):11-20. PubMed ID: 15893733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning, expression and functional characterization of miniature swine CD86.
    Choi I; Cho B; Kim SD; Park D; Kim JY; Park CG; Chung DH; Hwang WS; Lee JS; Ahn C
    Mol Immunol; 2006 Feb; 43(5):480-6. PubMed ID: 16337491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD89 (Fc alphaRI).
    Van Spriel AB; van de Winkel JG
    J Biol Regul Homeost Agents; 2001; 15(2):179-81. PubMed ID: 11501978
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.
    Chin LT; Chu C; Chen HM; Wang DW; Liao SK
    Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.
    Mukherjee P; Tinder TL; Basu GD; Gendler SJ
    J Leukoc Biol; 2005 Jan; 77(1):90-9. PubMed ID: 15513966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.